OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 11 results.
Search:

SKU Category Vector Description Price Delivery
SC121946 Human cDNA pCMV6-XL4 FXYD2 (untagged)-Human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant a NM_001680.3 $185 Immediate
RC205076 Human ORF PS100001 FXYD2 (Myc-DDK-tagged)-Human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant a $380 Immediate
RC205076L1 Human ORF PS100064 Lenti ORF clone of Human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant a , Myc-DDK-tagged $750 Immediate
RC205076L2 Human ORF PS100071 Lenti ORF clone of Human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant a, mGFP tagged $830 3-4 weeks
RG205076 Human ORF PS100010 FXYD2 (GFP-tagged) - Human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant a $420 Immediate
HP205498 Human Primer qSTAR qPCR primer pairs against Homo sapiens gene FXYD2 NM_001680 $95 3 - 5 Days
LY419804 Lysate LC419804 Transient overexpression lysate of FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant a $280 5 days
/ Mass Spec Standard FXYD2 MS Standard C13 and N15-labeled recombinant protein (NP_001671) $1500 3 weeks
TP305076 Protein Recombinant protein of human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant a $680 In Stock
HK203220 qPCR Standard qPCR primer pairs and template standards against Homo sapiens gene FXYD2 NM_001680 $295 5 - 7 Days
/ UTR pMirTarget 3`UTR clone of FXYD domain containing ion transport regulator 2 (FXYD2) transcript variant a for miRNA target validation NM_001680.4 $495 1 week
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title